Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme.

Saved in:
Bibliographic Details
Title: Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme.
Authors: Zhenjiang L; Division of Therapeutic Immunology (TIM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden., Rao M; Division of Therapeutic Immunology (TIM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden., Luo X; Division of Therapeutic Immunology (TIM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden., Valentini D; Division of Therapeutic Immunology (TIM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Centre for allogeneic stem cell transplantation (CAST), Karolinska University Hospital, Stockholm, Sweden., von Landenberg A; Division of Therapeutic Immunology (TIM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden., Meng Q; Division of Therapeutic Immunology (TIM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden., Sinclair G; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden; Department of Clinical Neuroscience, Section for Neurosurgery, Karolinska Institutet, Stockholm, Sweden., Hoffmann N; Division of Therapeutic Immunology (TIM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden., Karbach J; Department of Oncology and Haematology, Krankenhaus Nordwest, Frankfurt/Main, Germany., Altmannsberger HM; Institute of Pathology, Krankenhaus Nordwest, Frankfurt/Main, Germany., Jäger E; Department of Oncology and Haematology, Krankenhaus Nordwest, Frankfurt/Main, Germany., Peredo IH; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden; Department of Clinical Neuroscience, Section for Neurosurgery, Karolinska Institutet, Stockholm, Sweden., Dodoo E; Division of Therapeutic Immunology (TIM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden; Department of Clinical Neuroscience, Section for Neurosurgery, Karolinska Institutet, Stockholm, Sweden., Maeurer M; Division of Therapeutic Immunology (TIM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Centre for allogeneic stem cell transplantation (CAST), Karolinska University Hospital, Stockholm, Sweden. Electronic address: markus.maeurer@fundacaochampalimaud.pt.
Source: EBioMedicine [EBioMedicine] 2018 Jul; Vol. 33, pp. 49-56. Date of Electronic Publication: 2018 Jun 29.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30049387
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zhenjiang+L%22">Zhenjiang L</searchLink>; Division of Therapeutic Immunology (TIM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Rao+M%22">Rao M</searchLink>; Division of Therapeutic Immunology (TIM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Luo+X%22">Luo X</searchLink>; Division of Therapeutic Immunology (TIM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Valentini+D%22">Valentini D</searchLink>; Division of Therapeutic Immunology (TIM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Centre for allogeneic stem cell transplantation (CAST), Karolinska University Hospital, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22von+Landenberg+A%22">von Landenberg A</searchLink>; Division of Therapeutic Immunology (TIM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Meng+Q%22">Meng Q</searchLink>; Division of Therapeutic Immunology (TIM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Sinclair+G%22">Sinclair G</searchLink>; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden; Department of Clinical Neuroscience, Section for Neurosurgery, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Hoffmann+N%22">Hoffmann N</searchLink>; Division of Therapeutic Immunology (TIM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Karbach+J%22">Karbach J</searchLink>; Department of Oncology and Haematology, Krankenhaus Nordwest, Frankfurt/Main, Germany.<br /><searchLink fieldCode="AU" term="%22Altmannsberger+HM%22">Altmannsberger HM</searchLink>; Institute of Pathology, Krankenhaus Nordwest, Frankfurt/Main, Germany.<br /><searchLink fieldCode="AU" term="%22Jäger+E%22">Jäger E</searchLink>; Department of Oncology and Haematology, Krankenhaus Nordwest, Frankfurt/Main, Germany.<br /><searchLink fieldCode="AU" term="%22Peredo+IH%22">Peredo IH</searchLink>; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden; Department of Clinical Neuroscience, Section for Neurosurgery, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Dodoo+E%22">Dodoo E</searchLink>; Division of Therapeutic Immunology (TIM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden; Department of Clinical Neuroscience, Section for Neurosurgery, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Maeurer+M%22">Maeurer M</searchLink>; Division of Therapeutic Immunology (TIM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Centre for allogeneic stem cell transplantation (CAST), Karolinska University Hospital, Stockholm, Sweden. Electronic address: markus.maeurer@fundacaochampalimaud.pt.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101647039%22">EBioMedicine</searchLink> [EBioMedicine] 2018 Jul; Vol. 33, pp. 49-56. <i>Date of Electronic Publication: </i>2018 Jun 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101647039 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2352-3964 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223523964%22">23523964 </searchLink><i>NLM ISO Abbreviation: </i>EBioMedicine <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30049387
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ebiom.2018.06.014
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 49
    Titles:
      – TitleFull: Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhenjiang L
      – PersonEntity:
          Name:
            NameFull: Rao M
      – PersonEntity:
          Name:
            NameFull: Luo X
      – PersonEntity:
          Name:
            NameFull: Valentini D
      – PersonEntity:
          Name:
            NameFull: von Landenberg A
      – PersonEntity:
          Name:
            NameFull: Meng Q
      – PersonEntity:
          Name:
            NameFull: Sinclair G
      – PersonEntity:
          Name:
            NameFull: Hoffmann N
      – PersonEntity:
          Name:
            NameFull: Karbach J
      – PersonEntity:
          Name:
            NameFull: Altmannsberger HM
      – PersonEntity:
          Name:
            NameFull: Jäger E
      – PersonEntity:
          Name:
            NameFull: Peredo IH
      – PersonEntity:
          Name:
            NameFull: Dodoo E
      – PersonEntity:
          Name:
            NameFull: Maeurer M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2018 Jul
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 2352-3964
          Numbering:
            – Type: volume
              Value: 33
          Titles:
            – TitleFull: EBioMedicine
              Type: main
ResultId 1